aspirina

DACAB: Ticagrelor and Aspirin Improve Vein Graft Patency

According to this Chinese study,&nbsp;dual antiplatelet therapy&nbsp;with&nbsp;ticagrelor&nbsp;and&nbsp;aspirin&nbsp;improves vein graft patency a year after surgery without increasing the risk for major bleeding. &nbsp; Treatment with the P2Y12 inhibitor ticagrelor in combination with aspirin has been widely accepted for patients with acute coronary syndrome undergoing angioplasty. However, there were no related data regarding surgical revascularization. Read also:&nbsp;&#8220;Ticagrelor<a href="https://solaci.org/en/2017/11/16/dacab-ticagrelor-and-aspirin-improve-vein-graft-patency/" title="Read more" >...</a>

ARTE: ¿AsEl fin de la aspirina para los pacientes anticoagulados que reciben angioplastiapirina o aspirina más clopidogrel post TAVI?

The End of Aspirin for Anticoagulated Patients Undergoing PCI

The discussion about the best anti-thrombotic strategy for patients with&nbsp;atrial fibrillation&nbsp;undergoing PCI seemed never-ending until the RE-DUAL PCI trial was published in the New England Journal of Medicine (NEJM). This study has arrived to simplify the tough choice between the risk of a thrombotic event vs. the risk of bleeding with a simpler scheme, without<a href="https://solaci.org/en/2017/11/08/the-end-of-aspirin-for-anticoagulated-patients-undergoing-pci/" title="Read more" >...</a>

Nearly half of interventional cardiologists may have pre-cataract lesions

This statement is based on eye exams conducted during the last SCAI meeting (Society for Cardiovascular Angiography and Interventions), where 47% of evaluated operators had radiation related lesions in their crystalline. In time, these might turn into cataract. Studies on astronauts and Chernobyl survivors have shown a clear association between ionizing radiation and crystalline damage,<a href="https://solaci.org/en/2017/05/30/nearly-half-of-interventional-cardiologists-may-have-pre-cataract-lesions/" title="Read more" >...</a>

desensibilizacion a la aspirina

Aspirin Desensitization in Patients with Coronary Artery Disease

There are limited data on aspirin desensitization in patients with coronary artery disease (CAD). The aim of this study was to test the safety and efficacy of a rapid desensitization protocol inpatients with a history of aspirin sensitivity about to receive PCI. &nbsp; This was a prospective multicenter observational study, carried out in seven Italian<a href="https://solaci.org/en/2017/03/06/aspirin-desensitization-in-patients-with-coronary-artery-disease/" title="Read more" >...</a>

Top